Mint Med Review: What Its GLP-1 Prices Mean Before You Pay

A low monthly price is only useful if you know what will leave your account, when it will renew and what happens if treatment is not approved. Mint Med makes that calculation unusually difficult. The supplied pages advertise several prices for compounded semaglutide and tirzepatide, including monthly subscriptions and three- or six-month prepayments. They also give conflicting explanations of whether payment happens before or after clinical approval. Those differences matter more to an initial budget than the smallest number on a product page.

This documentary review examines Mint Med’s published materials consulted October 19, 2026. The business describes itself as an online platform connecting patients with independent licensed healthcare professionals and partner pharmacies, rather than providing every part of treatment itself. There are concrete prices and service inclusions to evaluate, but no single published offer reconciles all the pages. The practical task is to obtain a written, product-specific quote that connects the advertised rate to the actual charge, renewal interval, pharmacy fulfillment and cancellation terms.

At a glance

Semaglutide pricing differs: One compounded semaglutide listing charges $89 monthly; another charges $129 month-to-month; intake advertises a starting price of $106 monthly.
Sources: [11] [4] [5]
Tirzepatide payment options: The compounded tirzepatide listing shows $119 monthly, $330 every three months at an advertised $110 monthly equivalent, or $594 every six months at $99 monthly.
Sources: [12]
First-charge uncertainty: The homepage says payment is collected upfront for clinical review; a product page says payment is processed only after a provider approves a treatment plan.
Sources: [7] [4]
Renewal and cancellation: Intake establishes automatic renewal. The formal policy requires the official cancellation form at least 48 business hours before the next scheduled order processing date.
Sources: [5] [3]
Self-pay and compounded products: Terms say services are cash-pay only and insurance is not accepted. Mint Med discloses that its compounded semaglutide and tirzepatide are not FDA approved.
Sources: [8] [7]

Start with the amount collected, not the monthly equivalent

Mint Med’s lower-price compounded semaglutide listing offers three distinct payment choices: $89 billed every month, $255 billed every three months at an advertised $85 monthly equivalent, and $474 billed every six months at $79 monthly. The page labels these offers “Lifetime Price” and says all doses are included. Monthly delivery is expressly stated for the monthly option. The lower monthly equivalents belong to prepaid alternatives; they are not separate monthly installment offers.

The compounded tirzepatide listing follows a similar structure: $119 billed every month with monthly delivery, $330 billed every three months at $110 monthly, or $594 billed every six months at $99 monthly. It also advertises lifetime pricing and all doses included. These are meaningful billing distinctions, not merely different ways of displaying the same first payment. The supplied evidence does not fully define the lifetime-price promise, so it should not substitute for the renewal terms shown at checkout.

The table summarizes those two listings without treating either as a universal quote. An advertised package term does not, by itself, establish the exact quantity shipped, and the tirzepatide material does not clearly specify its administration route. The separate semaglutide page discussed below documents an injectable presentation through included injection supplies. For payment vocabulary, our guide to monthly and prepaid billing explains why a monthly equivalent and an actual recurring charge belong in different budget columns.

Selected advertised compounded-medication plans; other Mint Med pages show different prices.
Product and option	Advertised monthly amount	Published collection interval
Compounded semaglutide, monthly	$89	$89 every month
Compounded semaglutide, three months prepaid	$85	$255 every three months
Compounded semaglutide, six months prepaid	$79	$474 every six months
Compounded tirzepatide, monthly	$119	$119 every month
Compounded tirzepatide, three months prepaid	$110	$330 every three months
Compounded tirzepatide, six months prepaid	$99	$594 every six months

Sources: [11] [12] [4]

Other pages change the price comparison

A second compounded semaglutide page advertises $129 per month, billed month-to-month, with no coupon required and no separate membership, access or clinician-visit fee. That page also displays six months prepaid at $109 monthly and three months prepaid at $119 monthly. Its prepaid labels again advertise lifetime pricing and all doses included. These are materially different offers from the $89, $85 and $79 figures, not a rounding difference that a reader can safely disregard.

The intake flow introduces another set of figures: compounded semaglutide starts at $106 per month and compounded tirzepatide starts at $145 per month. That screen does not establish the plan commitment behind either starting price. There is no adequate basis in the supplied evidence to decide that one page supersedes another or that every applicant can select the lowest listing. Nor should these differences be relabeled as introductory versus renewal pricing when the pages do not establish that explanation.

Before paying, ask Mint Med to identify the exact offer attached to your application, the amount collected now and the next charge. Request the conditions behind “Lifetime Price,” including what happens after a plan change. Keep the quote with the checkout confirmation rather than relying on a separate promotional page. Our first-payment guide provides a framework for separating a headline monthly rate from the charge that actually authorizes enrollment.

Sources: [4] [5]

What the payment includes—and what it does not settle

The $129 semaglutide page gives the clearest bundle description: medication if prescribed, injection supplies, two-day cold shipping and clinician visits. It says there is no separate access fee or coupon requirement. Its three-month prepaid description additionally specifies a three-month supply, free cold shipping and supplies, and a full refund if not approved. These details belong to that documented offer; they should not automatically be transferred to every lower-priced listing without confirmation.

The homepage describes a broader service bundle covering full intake review, assessment of medical history, medications and eligibility, a telehealth visit if needed, unlimited care-team messaging and ongoing support. Those inclusions help explain what a payment buys beyond a shipment. However, the supplied evidence does not establish a mandatory follow-up schedule, laboratory requirements or whether any outside testing would be included. “Ongoing support” is useful language, but it is not a complete schedule of clinical services.

Mint Med’s terms say it does not accept insurance and that services are cash-pay only. They also assign patients responsibility for third-party charges. That provision deserves clarification alongside the product page’s inclusive pricing: ask which outside charges could still arise under your selected plan. The supplied materials do not explain the documentation or acceptance conditions behind an HSA/FSA eligibility heading. Our included-costs checklist can help separate explicitly bundled services from unresolved expenses.

Sources: [4] [7] [8]

The first charge and approval refund need written clarification

The homepage says payment is collected upfront to begin clinical review, while emphasizing that medication is prescribed only when medically appropriate. A semaglutide page similarly says portal access and the medical questionnaire arrive by email after payment; it estimates questionnaire completion at three to five minutes. Yet another passage on that product page promises a free, no-obligation evaluation and says payment is processed only if the provider approves a treatment plan. Those statements describe different payment sequences.

The practical uncertainty is not whether prescribing requires approval—it does—but whether money is collected while approval is still pending. Ask whether the checkout creates an immediate charge or another payment arrangement, and what happens if additional information is needed. The how-it-works page promises an immediate full refund for ineligibility. That is the provider’s stated refund promise, not evidence that a bank will make funds available immediately or that the same wording resolves every cancellation scenario.

The formal refund policy adds boundaries. Consultation fees become nonrefundable after a licensed provider has seen the patient, except when the provider determines medical ineligibility. Orders cannot be refunded once processed, regardless of whether they have shipped, and prescription returns are not accepted once filled and dispensed. An approval-related refund and a later change of mind are therefore different situations. Obtain the applicable approval, processing and refund rules before treating the first payment as reversible.

Sources: [7] [4] [3] [6]

Renewal makes cancellation part of the price

The intake agreement says plans renew automatically at the price and interval shown at checkout. It allows cancellation through the account or by emailing help@mintmed.com up to 48 business hours before the next renewal date. The formal cancellation policy instead requires the official cancellation form and says requests must arrive at least 48 business hours before the next scheduled order processing date. It states that requests inside that window cannot be honored.

These differences affect both the channel and the deadline’s reference point: renewal date on one page, order processing date on another. Do not reduce “48 business hours” to an assumed two-calendar-day window. Request the actual cutoff for your order, use the formal form and retain confirmation. An email may help document the issue, but the supplied evidence does not establish that email alone satisfies the formal policy. Ending renewal also does not establish a right to a refund.

Prepayment adds another financial condition. The policy says some subscriptions have three-, six- or twelve-month prepaid terms and that cancellation before completing the term requires paying the difference between promotional and full pricing. The supplied pages do not quantify that adjustment for each offer. That makes an early-exit calculation essential before choosing a prepaid rate. Our guide to cancellation and refunds explains why stopping future orders, reversing a processed order and recovering prepaid money are separate questions.

Sources: [5] [3]

Who reviews the application, and where service is available

Mint Med’s terms identify MINT MED, LLC as a platform connecting patients with independent licensed providers, not itself delivering medical services. The privacy policy instead identifies Glow Medispa, LLC doing business as Mint Med; their relationship is not explained in the supplied materials. An institutional page names Roderick Huff, MD, as founder and attributes more than two decades of experience to him. Intake claims every case receives review by a U.S. physician board-certified in obesity medicine; this review does not independently verify that credential.

Enrollment asks about symptoms, medical history and health goals. The intake also asks about GLP-1 use during the preceding two months and screens for several gastrointestinal, pancreatic, diabetes, thyroid-cancer, MEN-2 and eating-disorder histories. Brand names appearing as examples of prior medication use do not establish that Mint Med sells those brands. Depending on state requirements, consultation may involve scheduled live audio or video, or an asynchronous chart review followed by a recommendation in secure patient chat.

The terms limit service to U.S. residents who are at least 18, with some services potentially requiring age 21, and who are located in an operating state. Geography is not fully consistent: the homepage calls its coverage 35 states but lists 36 abbreviations, including California; the contact page lists 35 without California. California residents especially need direct confirmation. No supplied documentation establishes Mint Med’s specific BMI thresholds, required laboratory work or individualized approval criteria.

Sources: [8] [13] [9] [5] [7] [10]

Review, dispensing and delivery run on different clocks

Published review estimates range from six business hours on the how-it-works page to 24 business hours in one product passage and normally 48 business hours elsewhere, with variability expressly acknowledged. The homepage separately estimates prescription processing within 24–48 business hours after approval and shipping typically taking five to seven business days. Other passages advertise free overnight shipping or two-day cold shipping. None of these individual statements should be treated as a reliable total time from payment to arrival.

Mint Med says it coordinates care but does not manufacture, compound or dispense medication. It warns that the dispensing pharmacy, formulation, concentration, packaging and labeling may vary. Its contact page names RxCompoundStore Pharmacy in Fort Lauderdale and Southend Pharmacy in Houston as fulfillment partners. Intake says an approved prescription is cold-packed and shipped to the patient’s address, with nothing to collect in person. Tracking becomes available only after the pharmacy ships, not necessarily when clinical approval occurs.

For billing, address changes, medical questions and support, intake directs patients to the Elation Health Patient Portal. It specifically says Facebook and Instagram are not secure medical-support channels and lack pharmacy shipping information. The contact page lists calls or texts at +1-513-826-6142 and email at help@mintmed.com, with a U.S.-based care team available Monday through Friday, 9 a.m.–5 p.m. EST. That published schedule does not establish immediate human responses around the clock.

Sources: [4] [10] [6] [7] [5]

A compounded price is not an approved-product comparison

Mint Med discloses that its compounded semaglutide and tirzepatide are not FDA approved and have not undergone FDA review for safety, effectiveness or quality. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but neither a low price nor a clinician’s involvement establishes that a compounded preparation has the evidence of a particular approved product.

Because Mint Med says formulation, concentration and packaging can vary, the actual pharmacy product matters to both care and cost interpretation. Request its identity and clear administration instructions from the prescriber or pharmacist rather than drawing instructions from advertised dose-inclusive pricing. FDA has received reports of compounded-medication measuring or administration errors, some involving hospitalization. For an injectable GLP-1 delivery that arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy.

Mint Med also advertises a customizable non-GLP-1 MintFit kit that may include low-dose naltrexone, bupropion, metformin ER, inositol or orlistat depending on clinical needs. That is a separate offering, not evidence that every applicant receives a GLP-1 prescription or an equivalent substitute. More broadly, NIDDK describes follow-up as assessment of tolerance and response, not simply continued payment. A useful quote therefore needs to explain the ongoing care process as well as the recurring medication charge.

Sources: [4] [7] [1] [2]

Questions & answers

Is $89 Mint Med’s universal semaglutide price?

No universal rate is established. One compounded semaglutide listing advertises $89 billed monthly, while another shows $129 month-to-month and intake starts at $106 monthly. Prepaid offers introduce additional rates. Ask which exact listing applies to your application and whether the checkout amount, renewal price and included services match it.

Sources: [11] [4] [5]

Must I prepay six months to use Mint Med?

The documented product listings offer monthly options alongside prepaid alternatives, so six-month prepayment is not presented as universally required. The six-month compounded tirzepatide option collects $594 every six months; the lower-price semaglutide listing collects $474. Before choosing either, ask how the policy’s promotional-to-full-price adjustment would apply if you canceled early.

Sources: [11] [12] [3]

Will Mint Med charge me before clinical approval?

The supplied pages conflict. The homepage says payment is collected upfront for review, and a product page describes portal access after payment. Another product passage says payment is processed only after approval. Obtain written confirmation for your checkout. The stated ineligibility-refund promise does not establish when refunded money will reach your bank.

Sources: [7] [4] [6]

Can I cancel by emailing Mint Med?

Intake permits account or email cancellation, but the formal policy requires the official cancellation form. It also requires receipt at least 48 business hours before scheduled order processing, rather than merely before shipment. Use the formal form, retain confirmation and ask for the exact cutoff. Cancellation does not make an already processed order refundable.

Sources: [5] [3]

Does Mint Med accept insurance for these plans?

Its terms say insurance is not accepted and services are cash-pay only, with patients responsible for third-party costs. The $129 semaglutide offer describes medication if prescribed, supplies, cold shipping and clinician visits as included. Ask how those inclusions interact with possible outside charges; do not assume insurance reimbursement or HSA/FSA acceptance from promotional wording.

Sources: [8] [4]

Who should handle a delayed or questionable delivery?

Mint Med directs support and address questions to the Elation Health Patient Portal, and tracking appears only after pharmacy shipment. Its contact page also supplies phone, text and email support during stated weekday hours. If an injectable GLP-1 arrives warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or dispensing pharmacy.

Sources: [5] [10] [1]

Our assessment

Mint Med documents real payment choices, named pharmacy partners, bundled services and several support routes. Its monthly options offer an alternative to prepaid enrollment. The principal cost weakness is inconsistency: prices, first-charge timing, cancellation channels and delivery estimates do not line up across the supplied pages. Prepaid cancellation adjustments and the no-refund boundary at order processing also limit financial flexibility. A reasonable next step is a written quote specifying the exact compounded product, immediate charge, renewal amount and interval, included services, approval-refund rule and cancellation cutoff. If Mint Med cannot reconcile those points before payment, the lowest advertised monthly figure is not a dependable basis for budgeting.

Visit Mint Med’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Mint Med Review: What Its GLP-1 Prices Mean Before You Pay

At a glance

01Start with the amount collected, not the monthly equivalent

02Other pages change the price comparison

03What the payment includes—and what it does not settle

04The first charge and approval refund need written clarification

05Renewal makes cancellation part of the price

06Who reviews the application, and where service is available

07Review, dispensing and delivery run on different clocks

08A compounded price is not an approved-product comparison